Global Ovulation Testing Kits Market & Forecast to 2032

GURUGRAM, India - Sept. 9, 2026 - PRLog -- The global ovulation testing kits market was valued at USD 496.2 million in 2025 and is projected to reach USD 807.2 million by 2032, expanding at a CAGR of 7.2% during the forecast period. Ovulation testing kits are at-home fertility diagnostic tools primarily used to detect the luteinizing hormone (LH) surge that occurs shortly before ovulation, helping users identify their fertile window. The market includes urine-based, saliva-based, and digital testing solutions, with increasing adoption driven by growing fertility awareness, rising incidence of hormonal disorders, and increasing preference for convenient reproductive health monitoring.

Market growth is being supported by the increasing prevalence of polycystic ovary syndrome (PCOS) and other hormonal disorders, rising fertility concerns, greater awareness of assisted reproductive technologies such as IVF, and growing consumer interest in proactive fertility management. Technological advancements are also shifting the market beyond conventional test strips toward digital and smartphone-connected solutions that provide clearer results and enable users to track fertility data over time.

The market is also benefiting from the expansion of e-commerce and home healthcare, which has improved access to fertility testing products while offering consumers greater privacy and convenience. Integration of ovulation testing with fertility-tracking applications, telemedicine platforms, and connected reproductive health ecosystems represents a particularly attractive opportunity for manufacturers. North America currently holds the largest market share, while Asia Pacific is projected to be the fastest-growing regional market.

Key Company Profiles

• Church & Dwight Co., Inc.
• Clinical Guard LLC
• Fairhaven Health, LLC
• Geratherm Medical AG
• Ubio Biotechnology systems
• Hangzhou AllTest Biotech Co., Ltd.
• Mankind Pharma Ltd.
• Nantong Diagnos Biotechnology Co., Ltd.
• Premom Inc.
• SPD Swiss Precision Diagnostics GmbH

For more details, please visit: https://apeloconsulting.com/product/global-ovulation-test...

Data Source

Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise.